| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA ME |
|
Designated Validation States: |
|
KH MA MD TN |
| (30) |
Priority: |
17.07.2017 US 201762533207 P
29.08.2017 WO PCT/US2017/049191
|
| (71) |
Applicants: |
|
- Voyager Therapeutics, Inc.
Cambridge, Massachusetts 02139 (US)
- The Regents of the University of California
Oakland, CA 94607 (US)
|
|
| (72) |
Inventors: |
|
- KELLS, Adrian Philip
Upper Arlington, OH 43221 (US)
- SCHRECK, Stefan
St Duvall, Washington 98019 (US)
- LUTTICH, Edward H.
Fallbrook, California 92028 (US)
- BLOCH, Kenneth A.
San Diego, California 92128 (US)
- BANKIEWICZ, Krystof
Oakland, California 94607 (US)
|
| (74) |
Representative: Hoffmann Eitle |
|
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München
81925 München (DE) |
|
